Report overview
Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.
This report aims to provide a comprehensive presentation of the global market for Antimycobacterial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimycobacterial Drugs. This report contains market size and forecasts of Antimycobacterial Drugs in global, including the following market information:
Global Antimycobacterial Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antimycobacterial Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Antimycobacterial Drugs companies in 2022 (%)
The global Antimycobacterial Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.
We surveyed the Antimycobacterial Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antimycobacterial Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antimycobacterial Drugs Market Segment Percentages, by Type, 2022 (%)
Drugs Used for Tuberculosis
Drugs Used for Leprosy
Drugs Used for Atypical Mycobacteria
Global Antimycobacterial Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antimycobacterial Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Antimycobacterial Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antimycobacterial Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antimycobacterial Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antimycobacterial Drugs revenues share in global market, 2022 (%)
Key companies Antimycobacterial Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Antimycobacterial Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
GlaxoSmithKline
Bayer
AstraZeneca
Sanofi
Merck
Lupin
Macleods Pharmaceuticals
Systopic Laboratories
Zydus Cadila
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antimycobacterial Drugs, market overview.
Chapter 2: Global Antimycobacterial Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Antimycobacterial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antimycobacterial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antimycobacterial Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
